You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

Learn about the role of FeNO as a noninvasive test to identify type 2 inflammation in pediatric patients with asthma.


Learning objectives

  • Understand the role of FeNO in identifying pediatric patients with severe asthma


Review the diagnostic, predictive, and prognostic role of fractional exhaled nitric oxide (FeNO) as a biomarker in type 2 pediatric severe asthma.

MAT-US-2200770 v2.0 P - Expiration Date 02/28/2026

Related resources